Spots Global Cancer Trial Database for adult all
Every month we try and update this database with for adult all cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL) | NCT00560794 | Acute Lymphobla... | Blinatumomab (M... | 18 Years - | Amgen Research (Munich) GmbH | |
Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL) | NCT01209286 | B-ALL | Blinatumomab | 18 Years - | Amgen Research (Munich) GmbH | |
Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) | NCT01466179 | Acute Lymphobla... | Blinatumomab | 18 Years - | Amgen Research (Munich) GmbH | |
Study of the BiTE® Blinatumomab (MT103) in Adult Patients With Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia (ALL) | NCT01209286 | B-ALL | Blinatumomab | 18 Years - | Amgen Research (Munich) GmbH | |
Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL | NCT06175702 | Lymphoblastic L... Philadelphia-Po... Adult ALL | Vincristine Dexamethasone Imatinib Cytarabine Mercaptopurine Methotrexate Ponatinib allogeneic stem... Total body irra... Cyclophosphamid... Fludarabine | 18 Years - | PETHEMA Foundation | |
Confirmatory Phase II Study of Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL) | NCT01207388 | B-cell Acute Ly... | Blinatumomab | 18 Years - | Amgen Research (Munich) GmbH |